Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Other Accumulated Expenses (2011 - 2024)

Geron (GERN) posted Other Accumulated Expenses of $2.1 million for Q4 2024, down 34.29% sequentially from $3.2 million in Q3 2024, and up 155.65% YoY from $814000.0 in Q1 2024.

Geron (GERN) Other Accumulated Expenses (2011 - 2024) Analysis & Trends

Geron has reported Other Accumulated Expenses for 14 years, with the latest figure at $2.1 million in Q4 2024.

  • Quarterly Other Accumulated Expenses rose 155.65% year-over-year to $2.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $2.1 million (up 155.65% YoY) and the FY2024 annual result came in at $2.1 million, up 155.65% from the prior year.
  • Other Accumulated Expenses declined to $2.1 million in Q4 2024 per GERN's latest filing, from $3.2 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $3.2 million in Q3 2024 and troughed at $366000.0 in Q2 2022.
  • A 5-year average of $1.3 million and a median of $1.2 million in 2023 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses surged 452.19% in 2023, then dropped 16.72% in 2024.
  • Over 5 years, Other Accumulated Expenses stood at $388000.0 in 2020, then surged by 39.43% to $541000.0 in 2021, then declined by 5.73% to $510000.0 in 2022, then soared by 59.61% to $814000.0 in 2023, then jumped by 155.65% to $2.1 million in 2024.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $2.1 million, $3.2 million, and $1.7 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Geron 1.02 Mn -299.83 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 2.08 Mn
Sep 30, 2024 3.17 Mn
Jun 30, 2024 1.68 Mn
Mar 31, 2024 1.65 Mn
Dec 31, 2023 814,000.00
Sep 30, 2023 2.21 Mn
Jun 30, 2023 2.02 Mn
Mar 31, 2023 1.66 Mn
Dec 31, 2022 510,000.00
Sep 30, 2022 664,000.00
Jun 30, 2022 366,000.00
Mar 31, 2022 555,000.00
Dec 31, 2021 541,000.00
Dec 31, 2020 388,000.00
Dec 31, 2019 207,000.00
Dec 31, 2018 461,000.00
Sep 30, 2018 884,000.00
Jun 30, 2018 724,000.00
Mar 31, 2018 942,000.00
Dec 31, 2017 138,000.00